Clinical Trial Update: Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results assessing the safety and efficacy of once-daily KRP-104 added to metformin in adults with type 2 diabetes and inadequate glycemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• KRP-104

Snippet

Sponsor: ActivX Biosciences, Inc. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2014-06-26